Stavudine
- Generic Name
- Stavudine
- Brand Names
- Zerit
- Drug Type
- Small Molecule
- Chemical Formula
- C10H12N2O4
- CAS Number
- 3056-17-5
- Unique Ingredient Identifier
- BO9LE4QFZF
- Background
A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.
- Indication
For the treatment of human immunovirus (HIV) infections.
- Associated Conditions
- Human Immunodeficiency Virus (HIV) Infections
- Associated Therapies
- -
Dose Optimisation of Stavudine for the Treatment of HIV Infection
- Conditions
- Interventions
- First Posted Date
- 2016-02-02
- Last Posted Date
- 2016-02-02
- Lead Sponsor
- Willem Daniel Francois Venter
- Target Recruit Count
- 1077
- Registration Number
- NCT02670772
- Locations
- 🇿🇦
Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, Gauteng, South Africa
🇺🇬The Infectious Disease Institute (IDI), Mulago Hospital Complex, Kampala, Uganda
🇮🇳VHS-YRG Care Medical Centre, Chennai, Tamil Nadu, India
Differences Between Stavudine and Tenofovir Each Combined With Lamivudine and Efavirenz in SA HIV-infected Patients
- Conditions
- Interventions
- First Posted Date
- 2012-05-18
- Last Posted Date
- 2012-05-18
- Lead Sponsor
- University of Witwatersrand, South Africa
- Target Recruit Count
- 60
- Registration Number
- NCT01601899
- Locations
- 🇿🇦
Themba Lethu Clinic, Helen Joseph Hospital, Auckland Park, Johannesburg, Gauteng, South Africa
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
- Conditions
- Interventions
- First Posted Date
- 2007-09-14
- Last Posted Date
- 2018-03-14
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 97
- Registration Number
- NCT00528957
- Locations
- 🇵🇦
Hospital del Nino, Panama City, Panama
🇺🇸St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸Children's Diagnostic and Treatment Center, Inc, Fort Lauderdale, Florida, United States
Antiretroviral Therapy for Advanced HIV Disease in South Africa
- Conditions
- Interventions
- First Posted Date
- 2006-06-21
- Last Posted Date
- 2013-05-21
- Target Recruit Count
- 1771
- Registration Number
- NCT00342355
- Locations
- 🇿🇦
Mtubatuba SIckbay, Kwazulu-Natal, South Africa
🇿🇦Umtata Sickbay, Eastaern Cape, South Africa
🇿🇦South African Military Health Services (SAMHS), Centurion, South Africa
Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children
- Conditions
- Interventions
- First Posted Date
- 2006-04-07
- Last Posted Date
- 2021-11-02
- Target Recruit Count
- 44
- Registration Number
- NCT00312091
- Locations
- 🇹🇭
Siriraj Hospital Mahidol University CRS, Bangkok, Ratchathewi, Thailand
🇹🇭Chiang Mai University Pediatrics-Obstetrics CRS, Chiang Mai, Thailand
🇹🇭Chonburi Hosp. CRS, Chonburri, Thailand
Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities
- First Posted Date
- 2005-11-21
- Last Posted Date
- 2011-06-21
- Lead Sponsor
- CIPRA SA
- Target Recruit Count
- 812
- Registration Number
- NCT00255840
Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY
- Conditions
- First Posted Date
- 2005-10-10
- Last Posted Date
- 2005-10-25
- Lead Sponsor
- Groupe Hospitalier Pitie-Salpetriere
- Target Recruit Count
- 57
- Registration Number
- NCT00235222
- Locations
- 🇫🇷
Service de Maladies Infectieuses Hôpital Pitié-Salpêtrière, Paris, France
HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)
- Conditions
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2012-04-12
- Lead Sponsor
- Kirby Institute
- Target Recruit Count
- 80
- Registration Number
- NCT00192660
- Locations
- 🇦🇺
St. Vincent's Hospital, Sydney, New South Wales, Australia
2NN & CHARM Long-Term Follow-up Study
- Conditions
- First Posted Date
- 2005-08-09
- Last Posted Date
- 2007-04-30
- Target Recruit Count
- 763
- Registration Number
- NCT00127972
- Locations
- 🇦🇺
Holdsworth House Medical Practice, Darlinghurst, Australia
Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa
- Conditions
- Interventions
- First Posted Date
- 2005-01-05
- Last Posted Date
- 2014-08-27
- Lead Sponsor
- The Wistar Institute
- Target Recruit Count
- 30
- Registration Number
- NCT00100646
- Locations
- 🇿🇦
University of the Witwatersrand, Johannesburg, South Africa
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.